Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jacc.2024.05.034 | DOI Listing |
Eur Rev Med Pharmacol Sci
December 2024
Pharmaceutical Analysis Department, King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.
Objective: Time in therapeutic range (TTR) is a new approach to monitoring blood pressure (BP), providing a more accurate picture over time compared to the standard single BP measurement during a clinic visit. Currently, no study from Saudi Arabia has explored the use of TTR in assessing BP control and its related factors. Thus, we aimed to investigate them in this study.
View Article and Find Full Text PDFJAMA
December 2024
Section of Cardiovascular Medicine, Department of Medicine, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
Importance: In the US, approximately 10.55 million adults have atrial fibrillation (AF). AF is associated with significantly increased risk of stroke, heart failure, myocardial infarction, dementia, chronic kidney disease, and mortality.
View Article and Find Full Text PDFTher Adv Musculoskelet Dis
November 2024
Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, New Territories 999077, Hong.
Exp Gerontol
December 2024
Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China, National Institute of Health Data Science of China, Southern Medical University, Guangzhou, Guangdong, China. Electronic address:
Aims: To investigate the effect of optimal diastolic blood pressure (DBP) level on cardiovascular disease (CVD) events, considering different age groups. And the nonlinear relationship between DBP and CVD events by age were evaluated.
Methods: 358,734 participants of the UK biobank were included.
JAMA
December 2024
Department of Medicine, University of Chicago, Chicago, Illinois.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!